Table 1.
Treatment outcomes by time from diagnosis to treatment
| P | Total | 0-5 d | 6-10 d | 11-15 d | >15 d | |
|---|---|---|---|---|---|---|
| All ages, % (CI) | ||||||
| CR/CRi | <.001 | 1823/2369; 77.0 (75-79) | 1270/1584; 80.2 (78-82) | 331/465; 71.2 (67-75) | 109/157; 69.4 (62-7) | 113/163; 69.3 (62-76) |
| Death within 30 d | .619 | 170/2374; 7.2 (6.2-8.3) | 107/1587; 6.7 (5.6-8.1) | 38/466; 8.2 (5.8-11.0) | 11/157; 7.0 (3.5-12.2) | 14/164; 8.5 (4.7-13.9) |
| Death within 60 d | .173 | 275/2374; 11.6 (10.3-12.9) | 178/1587; 11.2 (9.7-12.9) | 64/466; 13.7 (10.7-17.2) | 12/157; 7.6 (4.0-13.0) | 21/164; 12.8 (8.1-18.9) |
| 2-y survival | <.001 | 43.9 (41.9-45.9) | 47.5 (45.1-50.1) | 36.0 (31.9-40.7) | 37.9 (31.0-46.4) | 36.7 (29.9-45.0) |
| ≤60 y, % (CI) | ||||||
| CR/CRi | .075 | 804/908; 88.5 (86.3-90.5) | 617/687; 89.8 (87.3-92.0) | 114/131; 87.0 (80.0-92.3) | 35/42; 83.3 (68.6-93.0) | 38/48; 79.2 (65.0-89.5) |
| Death within 30 d | .715 | 30/908; 3.3 (2.2-4.7) | 21/687; 3.1 (1.9-4.6) | 6/131; 4.6 (1.7-9.7) | 1/42; 2.4 (0.1-12.6) | 2/48; 4.2 (0.5-14.3) |
| Death within 60 d | .583 | 51/908; 5.6 (4.2-7.3) | 37/687; 5.4 (3.8-7.3) | 10/131; 7.6 (3.7-13.6) | 1/42; 2.4 (0.1-12.6) | 3/48; 6.2 (1.3-17.2) |
| 2-y survival | .252 | 60.7 (57.6-64.0) | 62.5 (58.9-66.3) | 56.0 (48.0-65.3) | 59.5 (46.4-76.4) | 49.8 (37.4-66.2) |
| >60 y, % (CI) | ||||||
| CR/CRi | .016 | 1019/1461; 69.7 (67.3-72.1) | 653/897; 72.8 (69.8-75.7) | 217/334; 65.0 (59.6-70.1) | 74/115; 64.3 (54.9-73.1) | 75/115; 65.2 (55.8-73.9) |
| Death within 30 d | .980 | 140/1466; 9.5 (8.1-11.2) | 86/900; 9.6 (7.7-11.7) | 32/335; 9.6 (6.6-13.2) | 10/115; 8.7 (4.2-15.4) | 12/116; 10.3 (5.5-17.4) |
| Death within 60 d | .354 | 224/1466; 15.3 (13.5-17.2) | 141/900; 15.7 (13.4-18.2) | 54/335; 16.1 (12.3-20.5) | 11/115; 9.6 (4.9-16.5) | 18/116; 15.5 (9.5-23.4) |
| 2-y survival | .077 | 33.4 (31.0-35.9) | 36.1 (33.3-39.4) | 28.2 (23.7-33.5) | 29.9 (22.6-39.7) | 31.2 (23.7-41.2) |
CI, confidence interval; CRi, CR with incomplete count recovery.